Morgan Stanley Maintains Underweight on Helmerich & Payne, Raises Price Target to $39
Benzinga Newsdesk 6 months ago
NewsPrice TargetAnalyst Ratings
Morgan Stanley analyst Daniel Kutz maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $35 to $39.
Morgan Stanley analyst Daniel Kutz maintains Helmerich & Payne (NYSE:HP) with a Underweight and raises the price target from $35 to $39.